Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2020 at the end of 30th June 2020 as follows. Summary Due to the highly disruptive impact of COVID-19
Interim Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.18 31.12.19 30.09.20 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,154 1,054 1,059 Total Assets 1,268 1,185 1,318 Current
Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.17 31.12.18 30.09.19 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,119 1,154 1,176 Total Assets 1,242 1,268 1,300 Current
revenue at a higher proportion than total expense as a result of the Company’s efficient cost management . Significant Events Financial Performance Management Discussion & Analysis Q1/2023 Executive Summary
contracted capacity of 544 MW equity. Page 5 3. Report and Analysis of the Operating Results EGCO would like to present analysis of the operation result as follows: Summary of operating results for Q2/2018
transaction value : 150 shares, at the price per share of Baht 49,000.-, amounting to Baht 7,350,000.- (8) Summary of Myanmar SPA-Today-Far East Company Limited financial status : Financial Statement March2015
increasing of employment and agricultural households are the key drivers of rising moderate growth. Summary of S&P Syndicate PCL operating performance of 3rd quarter Ending 30 September 2018 Revenue from Sales
138.3 million baht, which was an increase from the 3rd quarter of 2017 at 40.0 percent. The Company’s net profit margin stood at 28.7 percent. An increase of net profit was a result of the Company has
-1- AIT (VP-SEC) 018E/2018 August 9, 2018 Subject: Management's Discussion and Analysis of Operating Results for Q2-2018 To: The President of The Stock Exchange of Thailand Summary of Operations Q2
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company